Activation of cGAS/STING pathway upon TDP‐43‐mediated mitochondrial injury may be involved in the pathogenesis of liver fibrosis

Hui Yong,Shuai Wang,Fuyong Song

DOI: https://doi.org/10.1111/liv.14895

IF: 8.754

2021-04-19

Liver International

Abstract:<p>Recently, we read with great interest the article published in Cell by Yu <i>et al</i>, which reported that TAR DNA‐binding protein 43 (TDP‐43) overexpression stimulated the released of mitochondrial DNA (mtDNA) into the cytoplasm through mitochondrial permeability transition pore. Then, mtDNA bound to cyclic GMP‐AMP synthase (cGAS) to activate the cGAS/STING pathway, which caused the inflammation of amyotrophic lateral sclerosis (ALS).</p>

gastroenterology & hepatology

What problem does this paper attempt to address?

This paper attempts to explore the role of TDP-43-mediated mitochondrial damage in the pathogenesis of liver fibrosis. Specifically, the researchers found that overexpression of TDP-43 leads to the release of mitochondrial DNA (mtDNA) into the cytoplasm, which in turn activates the cGAS/STING pathway, causing an inflammatory response. This mechanism has been reported in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), but its role in liver fibrosis has not been fully studied.

The main findings of the paper include:
1. In the CCl₄-induced liver fibrosis mouse model, TDP-43 expression gradually increased, accompanied by the activation of the cGAS/STING signaling pathway and an increase in pro-inflammatory factors.
2. The co-localization of TDP-43 with mitochondria significantly increased, and this co-localization was associated with the severity of liver fibrosis.
3. The results suggest that TDP-43 may be involved in the occurrence of liver fibrosis by acting on mitochondria, upregulating the cGAS/STING pathway, and triggering an inflammatory response.

Although the study found an association between TDP-43 and liver fibrosis, further research is needed to validate these findings, particularly by conditionally knocking out the TDP-43 gene to confirm its causal relationship. These findings are expected to reveal key molecular mechanisms in the pathogenesis of liver fibrosis and provide new strategies for the prevention and treatment of liver fibrosis.